Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
RLL
AddedMar 20, 2024
UpdatedJun 18, 2026
RLL

RLL

Global biotech company in Lutherville Timonium, MD, specializing in phytochemical research and manufacturing.

HQ
Lutherville-Timonium, MD, US
Founded
2011
Overview
Compare
Fundraising
Employees

RLL LLC is a biotechmology company that researches and manufactures high quality phytochemicals and extracts worldwide.

It is headquartered in Lutherville, Maryland.

RLL - Similar Companies

Rjs Biologics logo

Rjs Biologics

RVL Pharmaceuticals logo

RVL Pharmaceuticals

rvlpharma.com

RLS Therapeutics logo

RLS Therapeutics

Rho Pharmaceuticals logo

Rho Pharmaceuticals

Phytoption logo

Phytoption

phytoption.com

HighlightLL Pharma logo

HighlightLL Pharma

SeqLL logo

SeqLL

seqll.com

Phytomedics logo

Phytomedics

Reiley Pharmaceuticals logo

Reiley Pharmaceuticals

BiotechInnova logo

BiotechInnova

biotechinnova.com

Phylos logo

Phylos

Oleolive logo

Oleolive

oleo.live

Carmolex logo

Carmolex

Rapalogix Health logo

Rapalogix Health

Rbio logo

Rbio

rbio.online

RLL - Quick Facts

Who are RLL's competitors?

Companies similar to RLL include Rjs Biologics, RVL Pharmaceuticals, RLS Therapeutics and Rho Pharmaceuticals.

When was RLL founded?

RLL was founded in 2011.

Where is RLL's headquarters located?

RLL's headquarters is located in Lutherville-Timonium, MD, US.

When was RLL's last funding round?

RLL's most recent funding round was for $8M (USD) in July 2021.

How much has RLL raised to-date?

As of Jul 27, 2021, RLL has raised a total of $9.6M (USD).

How many employees does RLL have?

RLL has 6 employees as of Feb 5, 2024.

RLL - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
  • Government
Main Product
  • Extracts
  • Phytochemicals
Tags
  • Distribution
NAICS
  • 320000Manufacturing
  • 325300Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing
  • 325320Pesticide and Other Agricultural Chemical Manufacturing
  • 325000Chemical Manufacturing
SIC
  • 2870Agricultural Chemicals
  • 2879Pesticides And Agricultural Chemicals, Not Elsewhere Classified
  • 2800Chemicals And Allied Products
Show 2 more industry codes
SIC
  • 2890Miscellaneous Chemical Products
  • 2899Chemicals And Chemical Preparations, Not Elsewhere Classified